173 related articles for article (PubMed ID: 24438183)
1. Identification of interferon-γ as a new molecular target of liver X receptor.
Wang Q; Ma X; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao R; Hajjar DP; Duan Y; Han J
Biochem J; 2014 Apr; 459(2):345-54. PubMed ID: 24438183
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.
Ma X; Wang Q; Liu Y; Chen Y; Zhang L; Jiang M; Li X; Xiang R; Miao RQ; Duan Y; Han J
Int J Cancer; 2015 Feb; 136(4):771-83. PubMed ID: 24947959
[TBL] [Abstract][Full Text] [Related]
3. Activation of liver X receptor induces macrophage interleukin-5 expression.
Chen Y; Duan Y; Kang Y; Yang X; Jiang M; Zhang L; Li G; Yin Z; Hu W; Dong P; Li X; Hajjar DP; Han J
J Biol Chem; 2012 Dec; 287(52):43340-50. PubMed ID: 23150660
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological LXR activation reduces presence of SR-B1 in liver membranes contributing to LXR-mediated induction of HDL-cholesterol.
Grefhorst A; Oosterveer MH; Brufau G; Boesjes M; Kuipers F; Groen AK
Atherosclerosis; 2012 Jun; 222(2):382-9. PubMed ID: 22481067
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ERK1/2 and activation of LXR synergistically reduce atherosclerotic lesions in ApoE-deficient mice.
Chen Y; Duan Y; Yang X; Sun L; Liu M; Wang Q; Ma X; Zhang W; Li X; Hu W; Miao RQ; Xiang R; Hajjar DP; Han J
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):948-59. PubMed ID: 25810299
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation of LXR ligand by D-Nap-GFFY hydrogel enhances anti-tumorigenic actions of LXR and removes LXR-induced lipogenesis.
Feng K; Ma C; Liu Y; Yang X; Yang Z; Chen Y; Xu T; Yang C; Zhang S; Li Q; Wei Z; Zhao D; Zeng P; Han J; Gao J; Chen Y; Duan Y
Theranostics; 2021; 11(6):2634-2654. PubMed ID: 33456564
[No Abstract] [Full Text] [Related]
7. Regulation of insulin resistance and adiponectin signaling in adipose tissue by liver X receptor activation highlights a cross-talk with PPARγ.
Zheng F; Zhang S; Lu W; Wu F; Yin X; Yu D; Pan Q; Li H
PLoS One; 2014; 9(6):e101269. PubMed ID: 24972069
[TBL] [Abstract][Full Text] [Related]
8. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
9. Association between liver X receptor-α and neuron-derived orphan nuclear receptor-1 in Kupffer cells of C57BL/6 mice during inflammation.
He K; Dai ZY; Li PZ; Zhu XW; Gong JP
Mol Med Rep; 2015 Oct; 12(4):6098-104. PubMed ID: 26239564
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
[TBL] [Abstract][Full Text] [Related]
11. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
Kappus MS; Murphy AJ; Abramowicz S; Ntonga V; Welch CL; Tall AR; Westerterp M
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):279-84. PubMed ID: 24311381
[TBL] [Abstract][Full Text] [Related]
12. 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.
Liu Y; Wei Z; Ma X; Yang X; Chen Y; Sun L; Ma C; Miao QR; Hajjar DP; Han J; Duan Y
J Lipid Res; 2018 Mar; 59(3):439-451. PubMed ID: 29298812
[TBL] [Abstract][Full Text] [Related]
13. Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.
Beyer C; Huang J; Beer J; Zhang Y; Palumbo-Zerr K; Zerr P; Distler A; Dees C; Maier C; Munoz L; Krönke G; Uderhardt S; Distler O; Jones S; Rose-John S; Oravecz T; Schett G; Distler JH
Ann Rheum Dis; 2015 Jun; 74(6):1317-24. PubMed ID: 24618263
[TBL] [Abstract][Full Text] [Related]
14. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
Blaschke F; Takata Y; Caglayan E; Collins A; Tontonoz P; Hsueh WA; Tangirala RK
Circ Res; 2006 Dec; 99(12):e88-99. PubMed ID: 17110595
[TBL] [Abstract][Full Text] [Related]
15. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
[TBL] [Abstract][Full Text] [Related]
16. Liver X receptor activation reduces angiogenesis by impairing lipid raft localization and signaling of vascular endothelial growth factor receptor-2.
Noghero A; Perino A; Seano G; Saglio E; Lo Sasso G; Veglio F; Primo L; Hirsch E; Bussolino F; Morello F
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2280-8. PubMed ID: 22723445
[TBL] [Abstract][Full Text] [Related]
17. Activation of liver X receptor alleviates ocular inflammation in experimental autoimmune uveitis.
Yang H; Zheng S; Qiu Y; Yang Y; Wang C; Yang P; Li Q; Lei B
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2795-804. PubMed ID: 24699378
[TBL] [Abstract][Full Text] [Related]
18. LXRalpha regulates human CETP expression in vitro and in transgenic mice.
Honzumi S; Shima A; Hiroshima A; Koieyama T; Ubukata N; Terasaka N
Atherosclerosis; 2010 Sep; 212(1):139-45. PubMed ID: 20494359
[TBL] [Abstract][Full Text] [Related]
19. Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.
Li Y; Bolten C; Bhat BG; Woodring-Dietz J; Li S; Prayaga SK; Xia C; Lala DS
Mol Endocrinol; 2002 Mar; 16(3):506-14. PubMed ID: 11875109
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
Yap F; Craddock L; Yang J
Int J Biol Sci; 2011; 7(5):645-50. PubMed ID: 21647332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
